Page last updated: 2024-11-08

methyldimethylaminoazobenzene and Cancer of Kidney

methyldimethylaminoazobenzene has been researched along with Cancer of Kidney in 2 studies

Methyldimethylaminoazobenzene: A very potent liver carcinogen.
3-methyl-4'-dimethylaminoazobenzene : A member of the class of azobenzenes that is azobenzene in which one of the phenyl groups is substituted at position 3 by a methyl group, while the other is substituted at position 4 by a dimethylamino group. It is a potent liver carcinogen.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martin, TJ1
Hunt, NH1
Boyd, H1
Ellison, M1
Michelangeli, VP1
Atkins, D1
Tsuda, H1
Ogiso, T1
Hasegawa, R1
Imaida, K1
Masui, T1
Ito, N1

Reviews

1 review available for methyldimethylaminoazobenzene and Cancer of Kidney

ArticleYear
Hormone receptors and cyclic nucleotide metabolism in cancer cells.
    Clinical endocrinology, 1976, Volume: 5 Suppl

    Topics: Adenocarcinoma; Adenoma; Adenylyl Cyclases; Animals; Calcitonin; Carcinoma, Hepatocellular; Cell Mem

1976

Other Studies

1 other study available for methyldimethylaminoazobenzene and Cancer of Kidney

ArticleYear
Inhibition of neoplastic development in rat liver, kidney, oesophagus and forestomach by 4,4'-diaminodiphenylmethane administration.
    Carcinogenesis, 1987, Volume: 8, Issue:5

    Topics: 2-Acetylaminofluorene; Aniline Compounds; Animals; Esophageal Neoplasms; Kidney Neoplasms; Liver Neo

1987